Quarterly report pursuant to Section 13 or 15(d)

Earnings (Loss) Per Common Share (Details)

v3.20.2
Earnings (Loss) Per Common Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Basic and diluted numerator:    
Net loss attributable to iBio, Inc. stockholders $ (7,533) $ (4,463)
Preferred stock dividends (66) (66)
Net loss available to iBio, Inc. stockholders $ (7,599) $ (4,529)
Basic and diluted denominator:    
Weighted-average common shares outstanding 162,442 21,923
Per share amount $ (0.05) $ (0.21)